证券代码：605296 证券简称：神农集团 公告编号：2025-104 云南神农农业产业集团股份有限公司 关于向 2025 年限制性股票激励计划激励对象 首次授予限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 限制性股票首次授予日：2025 年 8 月 27 日 ? 限制性股票首次授予数量：680 万股 《云南神农农业产业集团股份有限公司 2025 年限制性股票激励计划（草案）》 （以下简称"《激励计划（草案）》"或"本激励计划"）规定的限制性股票首次 授予条件已经成就，根据云南神农农业产业集团股份有限公司（以下简称"公司"） 第四次会议及第五届监事会第四次会议，审议通过了《关于向 2025 年限制性股票 激励计划激励对象首次授予限制性股票的议案》，确定以 2025 年 8 月 27 日为首次 授予日，向符合授予条件的 419 名激励对象授予 680 万股限制性股票，首次授予价 格为 17.35 元/股。现将有关事项说明如下： 一、本激励计划授予情况 （一）已履行的相关审批程序和信息披露情 ...

| | | | | | 占本激励计 | | | --- | --- | --- | --- | --- | --- | --- | | | | 获授予的限 | | 占授予限制 | | | | | | | | | 划首次授予 | | | 序号 职务 | 姓名 | | 制性股票数 | | 性股票总数 | | | | | | | | 日公司股本 | | | | | 量（万股） | | 的比例 | | | | | | | | | 总额的比例 | | | 一、董事、高级管理人员 | | | | | | | | 小计 | | 60.00 | | 7.06% | 0.11% | | | 二、其他激励对象 | | | | | | | | 中层管理人员/核心骨干（414 | | 人） | | 620.00 | 72.94% | 1.18% | | 三、预留部分 | | | 170.00 | 20.00% | 0.32% | | | 合计 | | 850.00 | | 100.00% | 1.62% | | | 注：1、公司全部在有效期内的股权激励计划所涉及的标的股票总数未超过公司股本总 | | | | | | | | 额的 | ...

Core Viewpoint - The legal opinion letter from Grandall Law Firm (Shanghai) addresses the adjustment of the grant price for the 2022 Restricted Stock Incentive Plan of Xiamen Weike Moulding Technology Co., Ltd, confirming that the adjustment has received necessary approvals and complies with relevant laws and regulations [4][6][8]. Summary by Sections Approval and Authorization of the Incentive Plan - The company held meetings on December 25, 2022, where the board and supervisory committee approved the draft of the 2022 Restricted Stock Incentive Plan and related proposals [4][5]. - On January 12, 2023, the company convened a temporary shareholders' meeting, which approved the incentive plan and authorized the board to handle related matters [5][6]. Adjustment Reasons and Methods - The adjustment of the grant price was due to the implementation of the 2024 profit distribution plan, which involved distributing cash dividends of 6 yuan per 10 shares to all shareholders [6][8]. - The adjustment method follows the formula: P = P0 - V, where P0 is the previous grant price, V is the dividend per share, and P is the adjusted grant price. The new grant price is set at 15.22 yuan per share [8]. Information Disclosure of the Incentive Plan - The law firm confirmed that the company has fulfilled its information disclosure obligations regarding the adjustment of the grant price, in accordance with relevant laws and regulations [8][9]. Conclusion Opinion - The law firm concludes that the adjustment of the grant price has obtained necessary approvals and complies with the Company Law and relevant regulations, and that the company has met its current information disclosure obligations [8][9].

证券代码：688595 证券简称：芯海科技 公告编号：2025-048 债券代码：118015 债券简称：芯海转债 芯海科技（深圳）股份有限公司 关于 2023 年限制性股票激励计划首次授予及预留授予 《关于提请公司股东大会授权董事会办 理股权激励相关事宜的议案》等议案。公司独立董事就本激励计划相关议案发表 了独立意见。 （一）2023 年激励计划已履行的决策程序和信息披露情况 通过了《关于公司<2023 年限制性股票激励计划（草案）>及其摘要的议案》 《关于 公司<2023 年限制性股票激励计划实施考核管理办法>的议案》《关于拟向董事长、 总经理卢国建先生授予限制性股票的议案》 部分第一个归属期归属结果暨股份上市的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为 本次股票上市流通总数为1,667,500股。 ? 本次股票上市流通日期为2025 年 8 月 29 日。 芯海科技（深圳）股份有限公司（以下简称"公司"）于近日收到中国证券登 ...

Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng Law Firm confirms that Jiangsu Hualv Biotechnology Group Co., Ltd. has fulfilled the necessary conditions for the second vesting period of its 2023 restricted stock incentive plan and addresses the cancellation of certain unvested restricted stocks [3][4][19]. Group 1: Approval and Authorization - The company has obtained the necessary approvals and authorizations for the implementation of the vesting and cancellation of restricted stocks, including relevant resolutions from the board of directors and supervisory board [7][12][19]. - The independent directors have expressed their agreement with the incentive plan and related resolutions [8][12]. Group 2: Vesting Conditions and Achievements - The second vesting period for the restricted stocks is defined as starting from the first grant date and lasting until the last trading day within 36 months [12][13]. - The vesting conditions include the absence of adverse audit opinions and compliance with performance targets, which have been met as of the date of the legal opinion [13][15]. Group 3: Cancellation of Restricted Stocks - Due to the departure of six incentive targets, a total of 180,000 shares of unvested restricted stocks will be canceled [17][18]. - The cancellation has been approved by the board of directors and does not require further shareholder approval [18][19]. Group 4: Information Disclosure - The company will disclose relevant resolutions and announcements regarding the vesting and cancellation of restricted stocks in accordance with applicable laws and regulations [19].

Core Viewpoint - The company has adjusted the grant price of the 2022 restricted stock incentive plan due to the implementation of the 2024 annual equity distribution, which aligns with relevant regulations and does not materially affect the company's financial status or operating results [5][6][8]. Group 1: Decision Process and Disclosure - The company held the 20th meeting of the fourth board and the 17th meeting of the fourth supervisory board on August 25, 2025, to approve the adjustment of the grant price for the 2022 restricted stock incentive plan [1][5]. - Independent directors provided their consent regarding the related proposals, and the independent financial advisor issued corresponding reports [1][4]. Group 2: Adjustment Details - The initial grant price of the restricted stock was adjusted from 6.40 yuan per share to 5.08 yuan per share, and the number of shares granted was increased from 1.943 million shares to 2.332 million shares [4][6]. - The adjustment formula for the grant price is defined as P = P0 - V, where P0 is the original grant price, V is the dividend per share, and P is the adjusted grant price [5][6]. Group 3: Impact and Opinions - The adjustment of the grant price is a result of the 2024 annual equity distribution and complies with the relevant laws and regulations, ensuring it does not harm the interests of minority shareholders [6][8]. - The supervisory board confirmed that the adjustment aligns with the interests of the company and all shareholders, and does not violate any legal provisions [6][8].

Core Points - The company has verified the list of incentive recipients for the 2025 Restricted Stock Incentive Plan, confirming that all recipients meet the eligibility criteria set forth in relevant laws and regulations [1][2] - The incentive plan includes 93 individuals who are eligible to receive a total of 380,000 shares of restricted stock at a grant price of 36 yuan per share, with the grant date set for August 26, 2025 [2] Summary by Sections Eligibility Verification - All recipients of the incentive plan have been confirmed to not fall under any disqualifying conditions as outlined in the management regulations [1] - The verification process ensures that the recipients have not been deemed inappropriate candidates by the securities exchange or regulatory bodies within the last 12 months [1] Compliance with Regulations - The list of incentive recipients aligns with the scope approved by the company's first extraordinary general meeting in 2025, confirming their qualifications [2] - The incentive plan does not include independent directors or those holding a significant stake in the company, ensuring compliance with regulatory requirements [2] Grant Details - The total number of restricted shares to be granted is 380,000, with a set price of 36 yuan per share, reflecting the company's commitment to incentivizing eligible employees [2]

证券代码：603605 证券简称：珀莱雅 公告编号：2025-041 债券代码：113634 债券简称：珀莱转债 珀莱雅化妆品股份有限公司 关于第四届监事会第五次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 珀莱雅化妆品股份有限公司（以下简称"公司"）第四届监事会第五次会议 通知于 2025 年 8 月 15 日以电子邮件方式送达全体监事，本次会议于 2025 年 8 月 25 日在公司会议室以现场方式召开。本次会议由监事会主席侯露婷女士主持， 会议应出席监事 3 人，实际出席监事 3 人。本次监事会会议的召集、召开符合《中 华人民共和国公司法》（以下简称"《公司法》"）、《珀莱雅化妆品股份有限 公司章程》（以下简称"《公司章程》"）的有关规定，决议内容合法有效。 二、监事会会议审议情况 （一）审议通过《公司 2025 年半年度报告及其摘要》 监事会认为： （1）公司严格按照会计准则规范运作，《公司 2025 年半年度报告》全文及 其摘要公允地反映了 2025 年半年度的财务状况和经营 ...

证券代码：000759 证券简称：中百集团 公告编号：2025-027 中百控股集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 中百控股集团股份有限公司（以下简称"公司"或"中百集团"）于 2025 年 通过了《关于回购注销部分限制性股票的议案》，现将有关情况公告如下： 一、公司 2022 年限制性股票激励计划已履行的相关审批程序 激励计划（草案）>及其摘要的议案》 《关于制定 <中百控股集团股份有限公司 ensp="ensp"> 年限制性股票激励计划管理办法>的议案》《关于制定 <中百控股集团股份有限公> 司 2022 年限制性股票激励计划实施考核管理办法>的议案》等相关议案，关联董 事回避了表决，独立董事发表了明确同意的独立意见，监事会对本次激励计划相 关事项进行了核查并发表了核查意见，公司聘请的律师出具了法律意见书。 转发的武汉市人民政府国有资产监督管理委员会（以下简称"武汉市国资委"） 《关于中百控股集团股份有限公司拟推行限制性股票激励计划的批复》（武国资 改革〔2022〕5 号），武汉市国资委原则同意公司实施限制性股票激励计划。 ...

湖北得伟君尚律师事务所 关于 中百控股集团股份有限公司 回购注销部分限制性股票事项的 法律意见书 地址：湖北省武汉市江汉区建设大道 588 号卓尔国际中心 20-21F（430000） 电子信箱：dewell@dewellcn.com 网址：http://www.dewellcn.com 二〇二五年八月 湖北得伟君尚律师事务所 关于中百控股集团股份有限公司 的法律意见书 （2025）得伟君尚字第 10400 号 致：中百控股集团股份有限公司 湖北得伟君尚律师事务所（以下简称"本所"）受中百控股集团股份有限公 司（以下简称"中百集团"或"公司"）委托，担任公司 2022 年限制性股票激 励计划（以下简称"本激励计划"或"本计划"）的专项法律顾问，就本激励计 划本次回购注销部分限制性股票（以下简称"本次回购注销"）之相关事项出具 本法律意见书。 为出具本法律意见书，本所律师审阅了《中百控股集团股份有限公司 2022 年限制性股票激励计划》（以下简称《激励计划》）、《中百控股集团股份有限 公司 2022 年限制性股票激励计划管理办法（修订稿）》、《中百控股集团股份 有限公司 2022 年限制性股票激励计划实施考核管 ...